Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Sep;67(9):1102-8.
doi: 10.1001/archneurol.2010.197.

Elevated intrathecal myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis

Affiliations

Elevated intrathecal myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis

Eric C Klawiter et al. Arch Neurol. 2010 Sep.

Abstract

Objective: To evaluate antibodies to myelin oligodendrocyte glycoprotein (MOG) in the serum and cerebrospinal fluid (CSF) of patients with multiple sclerosis (MS) and control individuals.

Design: Prospective case-control series.

Setting: Academic referral center.

Patients: Twenty-six controls with noninflammatory neurologic disease and 35 patients with MS donated serum and CSF for recombinant MOG (rMOG) antibody determination.

Main outcome measures: Serum and CSF rMOG antibody and albumin levels were used to calculate an rMOG index. Clinical disability, CSF markers, and magnetic resonance metrics were correlated with the rMOG index.

Results: The rMOG index was elevated in MS patients compared with controls (P = .01). Patients with progressive MS exhibited elevated rMOG indexes compared with patients with relapsing-remitting MS (P = .04). The rMOG index was inferior to the IgG index in differentiating MS patients from controls. However, 7 of 16 patients with MS who had normal immunoglobulin G indexes had an elevated rMOG index. The rMOG index did not correlate with clinical disability, other CSF markers, or radiographic outcome measures.

Conclusions: The rMOG index, a marker of intrathecal MOG antibody production, may provide complementary information to routine CSF testing in the diagnosis of MS. Furthermore, intrathecal anti-MOG antibody production may be more pronounced in progressive than in relapsing forms of MS.

PubMed Disclaimer

Figures

Figure 1
Figure 1
rMOG index in controls versus MS. The box plot compares rMOG indices between 26 control subjects and 35 MS subjects. MS subjects have elevated rMOG indices compared to controls (p=0.012).
Figure 2
Figure 2
rMOG indices of MS subtypes. A box plot of controls, and MS subjects separated by disease subtype (RRMS, SPMS, PPMS) reflects elevated rMOG index in progressive MS subjects (p=0.041).
Figure 3
Figure 3
Receiver Operator Curve (ROC) of rMOG index and IgG index. A larger area under the curvereflects a better diagnostic test. TheROC demonstrates superiority of IgG index (area under the curve 0.891) over rMOG index (0.685) as a diagnostic test for differentiating MS from controls.

References

    1. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med. 2000 Sep 28;343(13):938–952. - PubMed
    1. Thompson EJ, Kaufmann P, Shortman RC, Rudge P, McDonald WI. Oligoclonal immunoglobulins and plasma cells in spinal fluid of patients with multiple sclerosis. Br Med J. 1979 Jan 6;1(6155):16–17. - PMC - PubMed
    1. Genain CP, Cannella B, Hauser SL, Raine CS. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat Med. 1999 Feb;5(2):170–175. - PubMed
    1. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol. 2000 Jun;47(6):707–717. - PubMed
    1. Archelos JJ, Storch MK, Hartung HP. The role of B cells and autoantibodies in multiple sclerosis. Ann Neurol. 2000 Jun;47(6):694–706. - PubMed

Publication types

Substances